<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND/AIMS: Genetic risk factors have not been clearly established for vascular <z:hpo ids='HP_0000726'>dementias</z:hpo> (VaD) related to <z:hpo ids='HP_0001297'>stroke</z:hpo> and cerebrovascular disease </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Samples were genotyped for APOE, MTHFR and ICAM </plain></SENT>
<SENT sid="2" pm="."><plain>Aβ levels and <z:chebi fb="3" ids="15354">choline</z:chebi> acetyltransferase (ChAT) activities were assayed in controls and individuals with VaD </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Associations were found between the APOE-ε4 allele and mixed <z:hpo ids='HP_0000726'>dementia</z:hpo>, <z:mpath ids='MPATH_124'>infarct</z:mpath>/<z:hpo ids='HP_0001297'>stroke</z:hpo> <z:hpo ids='HP_0000726'>dementia</z:hpo> and subcortical ischemic vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (SIVD), and higher Aβ1-42 levels and decreased ChAT activity </plain></SENT>
<SENT sid="4" pm="."><plain>MTHFR was more associated with SIVD, mixed <z:hpo ids='HP_0000726'>dementia</z:hpo>, and lower ChAT activity </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: The study demonstrates important differences in the genetic associations of VaD and begins to clarify the genetic basis of key pathological substrates </plain></SENT>
</text></document>